ART Advanced Research Technologies Announces 2006 Third Quarter Financial Results
14th Nov 2006, 13:29 GMT
ART Advanced Research Technologies Inc. (ART) (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today...
ART Advanced Research Technologies Announces 2006 Third Quarter Financial Results related news:
- ART Advanced Research Technologies Inc.: ART Advanced Research Technologies Announces 2006 Third Quarter Financial Results — Market Wire - Earnings Reports
- / CORRECTION - Rosetta Resources Announces Third Quarter 2006 Financial and Operating Results — ArriveNet : Press Releases
- Adherex Reports Third Quarter 2006 Financial Results — ArriveNet : Press Releases
- Jaclyn Reports First Quarter Financial Results; Announces Developments Concerning Purchase Option on West New York Facility — ArriveNet : Press Releases
- O2Diesel Announces Third Quarter 2006 Financial Results — ArriveNet : Autos
- JMAR Technologies Reports Q3 2006 Results — StratWire - Business of Healthcare NewsFeed
- Cordia Corporation Announces Financial Results for the Third Quarter of 2006 — VoIP Developer
- Rosetta Resources Announces Third Quarter 2006 Financial and Operating Results — ArriveNet : Press Releases
- IdleAire Technologies Corporation Announces Third Quarter 2006 Operating Results - Third quarter revenues increased by 133% to $4.7 million — mysan.de - Lifestyle News
- Merrimac Announces Third Quarter 2006 Financial Results and Conference Call Information — VoIP Developer
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- PuriCore Plc announces Appointment
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL